Investorideas.com


Be a guest or sponsor our podcasts - learn more about us : 800 665 0411


Share on StockTwits

Cannabis / Therapeutic Stock News: American Premium Water Corp (OTC: $HIPH) Expanded Vanexxe Varicose Vein Treatment Product Distribution in Australia with Nutra Pty. Ltd

The global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, growing at a CAGR of 5.7% from 2018 to 2025.- Allied Market Research

PLAYA VISTA, CA - January 31, 2020 (Newsfile Corp.) (Investorideas.com Newswire) American Premium Water Corporation (OTC: HIPH) recently reported that Canyon Create Corp, the manufacturer of Vanexxe, has entered into a Letter of Intent (LOI) with Nutra Pty. Ltd. (Nutra), an Australian corporation with extensive reach in distribution of personal products, to engage in the licensed production and sale of Vanexxe throughout Australia and Southeast Asia. The Company has an equitable interest in Canyon Create Corp.

American Premium Water Corporation CEO Ryan Fishoff commented, "This is an exciting day for Vanexxe! Not only is this ground breaking product expanding to Australia, its also being evaluated by the TGA to be classified for therapeutic use. If approval is given, it will greatly expand the number of channels that can sell the product. It will also offer further validation of the product and its efficacy. The LOI with Nutra Pty falls in line with our focus on international expansion, and has been in the works for some time, as the Company stated back in July that it was in discussions with distributors across the Pacific Rim. Establishing a foothold in the Pacific has been a stated goal of the Company's. As we move into 2020, we will continue to focus on expanding into this region. I look forward to updating shareholders when the Nutra Pty LOI is completed and the Company's other activities in the area."

The Therapeutic Goods Administration (TGA) is the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia. The LOI with Nutra stipulates that they would be responsible for the manufacturing and distribution of Vanexxe in Australia and surrounding regions in Southeast Asia. Nutra will also take the lead in shepherding the product through the approval process of the TGA. Australia is one of the world's largest economies, having the 14th largest GDP globally.

Canyon Create Founder and President, Campbell McAuley, said: "This is the most encouraging news to date that we will be able to have our products marketed extensively in Australia and in the Southeast Asian region based on this anticipated approval by the TGA. We are confident that Nutra is an excellent manufacturing partner that will be able to meet our expectations, resulting in what we project will be the production and sale of hundreds of thousands of units of Vanexxe, as well as our other skin care topical brands."

LALPINA CBD water can be purchased online at visiting https://www.singleseed.com/product/lalpina-cbd-water-6-pack/

LYNKS Pet CBD Water can be purchased online:

https://www.singleseed.com/product/lynks-cbd-pet-water-6-pack/

Vanexxe can be purchased on Amazon here

https://www.amazon.com/Vanexxe-Varicose-Vein-Treatment-appearance/dp/B07R634ZPZ/ref=sr_1_1?keywords=Vanexxe&qid=1573792143&sr=8-1

Vanexxe Varicose Vein Treatment - vein support for varicose veins and to help reduce the appearance of varicose veins


Price: $49.99 ($25.00 / Fl Oz)

  • VISIBLE RESULTS IN 45 minutes - 2 hours THANKS TO THESE ALL NATURAL INGREDIENTS Ginko Biloba, Activated B Vitamins, Antioxidants, and Peptides
  • We pride ourselves on lab-tested, pesticide, metal, toxin, and cruelty free products. All of our product ingredients are ethically formulated in FDA approved laboratories and CGMP compliant facilities. We insure performance-based ethical products with the collaboration of industry leading dermatologists, clinicians, aroma therapists, skincare specialists and beauty experts.

The Company's research report was recently updated by Ludlow Research with a short-term price target of $0.03. To read full report, risks, and disclosures, click here

About American Premium Water Corp.

American Premium Water (HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company's portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com), Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) and plant + body essentials (www.plantbodyessentials.com).

American Premium Water strives in providing only the highest quality CBD sources for its products, with quality control being one of our first and foremost focuses. The Company aims for this standard not only for compliance reasons, but also to provide our customers the highest quality product possible.

About Canyon Create Corp.

Canyon Create Corp., a Nevada Corporation, is the developer of Vanexxe (www.vanexxe.com), a patented cosmetic cream that uses a proprietary formulation to eliminate the appearance of varicose veins. The product works by simultaneously bringing heightened blood flow to the bulged vein valve, allowing it to pull away from the dermis and return to a more normal condition, and increases the elasticity in the upper skin layers to provide healthier skin, assisting in moving the vein back to a non-visible location.

Safe Harbor Notice

Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.

This press release is issued on behalf of the Board of Directors of American Premium Water Corporation.

Investor Relations

888-983-0054

info@americanpremiumwater.com

The global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, growing at a CAGR of 5.7% from 2018 to 2025.- Allied Market Research

News - Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release HIPH is a paid for news release on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com

https://www.investorideas.com/About/

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp